Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $70,156.40 +1.96%
Ethereum $2,078.33 +1.27%
BNB $636.04 +3.14%
Optimism $0.20 +2.49%
Arbitrum $0.12 +3.42%
Solana $88.88 +4.83%
Polygon $0.22 +2.77%
Cosmos $2.19 +2.87%
Avalanche $9.63 +5.03%

Bitcoin $70,156.40 +1.96%
Ethereum $2,078.33 +1.27%
BNB $636.04 +3.14%
Optimism $0.20 +2.49%
Arbitrum $0.12 +3.42%
Solana $88.88 +4.83%
Polygon $0.22 +2.77%
Cosmos $2.19 +2.87%
Avalanche $9.63 +5.03%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B